Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2006-8-10
pubmed:abstractText
To investigate the combined antitumor activity in mice of immunotoxin SS1P and Taxol. Methods: Immunodeficient mice were implanted with A431/K5 tumors expressing mesothelin. Established tumors were treated i.v. with immunotoxin SS1P alone, i.p. with Taxol alone, or with the two agents together. SS1P was radiolabeled with (111)In and used to study the effect of Taxol on its uptake by A431/K5 tumors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4695-701
pubmed:meshHeading
pubmed-meshheading:16899620-Animals, pubmed-meshheading:16899620-Antibodies, Monoclonal, pubmed-meshheading:16899620-Antineoplastic Agents, pubmed-meshheading:16899620-Carcinoma, pubmed-meshheading:16899620-Cell Line, Tumor, pubmed-meshheading:16899620-Cell Proliferation, pubmed-meshheading:16899620-Combined Modality Therapy, pubmed-meshheading:16899620-Disease Models, Animal, pubmed-meshheading:16899620-Dose-Response Relationship, Drug, pubmed-meshheading:16899620-Drug Synergism, pubmed-meshheading:16899620-Humans, pubmed-meshheading:16899620-Injections, Intraperitoneal, pubmed-meshheading:16899620-Injections, Subcutaneous, pubmed-meshheading:16899620-Mice, pubmed-meshheading:16899620-Mice, Nude, pubmed-meshheading:16899620-Paclitaxel, pubmed-meshheading:16899620-Structure-Activity Relationship, pubmed-meshheading:16899620-Xenograft Model Antitumor Assays
pubmed:year
2006
pubmed:articleTitle
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice.
pubmed:affiliation
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4264, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Intramural